Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination

In a Perspective, Ajit Lalvani and colleagues discuss new approaches to predicting progression to active tuberculosis.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS medicine 2019-05, Vol.16 (5), p.e1002814-e1002814
Hauptverfasser:	Lalvani, Ajit, Berrocal-Almanza, Luis C, Halliday, Alice
Format:	Artikel
Sprache:	eng
Schlagworte:	Antitubercular Agents - therapeutic use Biology and Life Sciences Care and treatment College campuses Communicable diseases Constraining Control Development and progression Diagnosis Disease Disease prevention Disease Progression Disease transmission Early Diagnosis Epidemiologic methods Gene expression Genomes Health risk assessment Humans Immigrants Incidence Infections Interferon Interferon-gamma Release Tests Inventors Latent Tuberculosis - diagnosis Latent Tuberculosis - drug therapy Latent Tuberculosis - epidemiology Latent Tuberculosis - transmission Lungs Medical research Medicine and Health Sciences Mortality Patient outcomes Predictive Value of Tests Ribonucleic acid Rifapentine Risk Factors RNA Signatures Skin tests Tuberculin Tuberculin Test Tuberculosis Tuberculosis, Pulmonary - diagnosis Tuberculosis, Pulmonary - epidemiology Tuberculosis, Pulmonary - prevention & control Tuberculosis, Pulmonary - transmission
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In a Perspective, Ajit Lalvani and colleagues discuss new approaches to predicting progression to active tuberculosis.
ISSN:	1549-1676 1549-1277 1549-1676
DOI:	10.1371/journal.pmed.1002814